Vesicular glutamate transporter 1: Difference between revisions
Content deleted Content added
added SLC cat + navbox + see also section |
Lilac Soul (talk | contribs) |
||
Line 71: | Line 71: | ||
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }} |
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }} |
||
*{{cite journal | author=Ota T, Suzuki Y, Nishikawa T, ''et al.'' |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40-5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }} |
*{{cite journal | author=Ota T, Suzuki Y, Nishikawa T, ''et al.'' |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40-5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }} |
||
*{{cite journal | author=Eastwood SL, Harrison PJ |title=Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. |journal= |
*{{cite journal | author=Eastwood SL, Harrison PJ |title=Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. |journal=[[Schizophrenia Research]] |volume=73 |issue= 2-3 |pages= 159-72 |year= 2005 |pmid= 15653259 |doi= 10.1016/j.schres.2004.05.010 }} |
||
*{{cite journal | author=Alonso-Nanclares L, De Felipe J |title=Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex. |journal=Neuroscience |volume=134 |issue= 1 |pages= 59-68 |year= 2005 |pmid= 15961236 |doi= 10.1016/j.neuroscience.2005.03.038 }} |
*{{cite journal | author=Alonso-Nanclares L, De Felipe J |title=Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex. |journal=Neuroscience |volume=134 |issue= 1 |pages= 59-68 |year= 2005 |pmid= 15961236 |doi= 10.1016/j.neuroscience.2005.03.038 }} |
||
*{{cite journal | author=Vinatier J, Herzog E, Plamont MA, ''et al.'' |title=Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis. |journal=J. Neurochem. |volume=97 |issue= 4 |pages= 1111-25 |year= 2006 |pmid= 16606361 |doi= 10.1111/j.1471-4159.2006.03821.x }} |
*{{cite journal | author=Vinatier J, Herzog E, Plamont MA, ''et al.'' |title=Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis. |journal=J. Neurochem. |volume=97 |issue= 4 |pages= 1111-25 |year= 2006 |pmid= 16606361 |doi= 10.1111/j.1471-4159.2006.03821.x }} |
Revision as of 20:22, 26 February 2008
Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, also known as SLC17A7, is a human gene.[5]
See also
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000104888 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000070570 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Entrez Gene: SLC17A7 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7".
Further reading
This article incorporates text from the United States National Library of Medicine, which is in the public domain.